aTyr Pharma(DE:471)
€0.230.00 (0.00%)
DE:471
aTyr Pharma earnings date
€0.23
At close:0.00 (0.00%)
aTyr Pharma (471) Q2 2023 Earnings Report
14 Followers
DE:471 Q2 2023 EPS Results
- Actual EPS
- -EUR 7.88
- Consensus EPS
- -EUR 9.98
- Beat/Miss
- Beat by +EUR 2.10
- One Year Ago EPS
- -EUR 15.76
DE:471 Q2 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 547.95K
- Beat/Miss
- Missed by -EUR 547.95K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/09/2023
- Time
- After Close
- Conference Call
- Wednesday, August 9, 2023
DE:471 Upcoming Earnings
aTyr Pharma's next earnings date is estimated for March 18, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:471 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 18, 2027 | 2026 (Q4) | -5.38- | -5.01 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -5.63-6.65 | -9.31 | 28.56% (+2.66) | |
| Aug 07, 2026 | 2026 (Q2) | -4.35-3.94 | -7.88 | 50.00% (+3.94) | |
| May 15, 2026 | 2026 (Q1) | -4.75-3.94 | -6.09 | 35.29% (+2.15) | |
| Mar 05, 2026 | 2025 (Q4) | -6.58-5.01 | -6.45 | 22.22% (+1.43) | |
| Nov 06, 2025 | 2025 (Q3) | -6.58-9.31 | -8.24 | -13.04% (-1.07) | |
| Aug 07, 2025 | 2025 (Q2) | -6.61-7.88 | -8.24 | 4.35% (+0.36) | |
| May 07, 2025 | 2025 (Q1) | -6.84-6.09 | -8.24 | 26.09% (+2.15) | |
| Mar 13, 2025 | 2024 (Q4) | -8.08-6.45 | -8.95 | 28.00% (+2.51) | |
| Nov 07, 2024 | 2024 (Q3) | -7.88-8.24 | -7.16 | -15.00% (-1.07) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
